Related Experiment Video
Updated: Jan 28, 2026

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
Skin and Soft Tissue Models for Acinetobacter baumannii Infection
Daniel V Zurawski1, Jaideep Banerjee2, Yonas A Alamneh2
1Wound Infections Department, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA. daniel.v.zurawski.civ@mail.mil.
Multidrug-resistant Acinetobacter baumannii infections pose significant challenges. This chapter details established animal models for evaluating new treatments against these difficult-to-treat Gram-negative pathogens.
Area of Science:
- Microbiology
- Infectious Diseases
- Animal Models
Background:
- Multidrug-resistant Acinetobacter baumannii (MDR AB) are critical Gram-negative pathogens.
- These bacteria cause persistent wound infections in burn and trauma victims, leading to complications like delayed healing, graft failure, sepsis, and amputation.
- Limited antibiotic options necessitate novel therapeutic development.
Purpose of the Study:
- To describe established in vivo models for evaluating treatments against MDR AB skin and soft tissue infections.
- To address the challenge of assessing safety and efficacy due to a lack of standardized models.
Main Methods:
- Review of established rodent models for studying AB infections.
- Description of large animal models utilized for similar investigations.
- Focus on models relevant to skin and soft tissue infections.
Main Results:
- Established rodent and large animal models exist for studying AB infections.
- These models facilitate the investigation of treatment efficacy and safety.
- The models are crucial for advancing the development of new antibacterials.
Conclusions:
- Well-established in vivo models are essential for evaluating new treatments against MDR AB.
- Rodent and large animal models provide valuable platforms for this research.
- These models are critical for overcoming challenges in developing effective therapies for AB infections.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
08:37The Application of Open Searching-based Approaches for the Identification of Acinetobacter baumannii O-linked Glycopeptides
Published on: November 2, 2021
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tissues
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Sensory Functions of the Skin
There are two main categories of receptors on the skin: capsulated and non-capsulated. The non-capsulated ones are mainly the pain receptors. The capsulated ones can be further categorized based on the...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...